Review and evaluation of the potential impact of age-and gender-specific pharmacokinetic differences on tissue dosimetry
HJ Clewell, J Teeguarden, T McDonald… - Critical reviews in …, 2002 - Taylor & Francis
In standard risk assessment methods for carcinogenic or noncarcinogenic chemicals,
quantitative methods for evaluating interindividual variability are not explicitly considered …
quantitative methods for evaluating interindividual variability are not explicitly considered …
[PDF][PDF] Review and Evaluation of the Potential Impact of Age-and Gender-Specific Pharmacokinetic Differences on Tissue Dosimetry
HJ Clewell, J Teeguarden, T McDonald… - Critical Reviews in …, 2002 - researchgate.net
In standard risk assessment methods for carcinogenic or noncarcinogenic chemicals,
quantitative methods for evaluating interindividual variability are not explicitly considered …
quantitative methods for evaluating interindividual variability are not explicitly considered …
Review and evaluation of the potential impact of age-and gender-specific pharmacokinetic differences on tissue dosimetry
HJ Clewell, J Teeguarden, T McDonald… - Critical Reviews in …, 2002 - search.proquest.com
In standard risk assessment methods for carcinogenic or noncarcinogenic chemicals,
quantitative methods for evaluating interindividual variability are not explicitly considered …
quantitative methods for evaluating interindividual variability are not explicitly considered …
Review and evaluation of the potential impact of age-and gender-specific pharmacokinetic differences on tissue dosimetry
HJ Clewell, J Teeguarden… - Critical reviews in …, 2002 - pubmed.ncbi.nlm.nih.gov
In standard risk assessment methods for carcinogenic or noncarcinogenic chemicals,
quantitative methods for evaluating interindividual variability are not explicitly considered …
quantitative methods for evaluating interindividual variability are not explicitly considered …
[PDF][PDF] Review and Evaluation of the Potential Impact of Age-and Gender-Specific Pharmacokinetic Differences on Tissue Dosimetry
HJ Clewell, J Teeguarden, T McDonald… - Critical Reviews in …, 2002 - scholar.archive.org
In standard risk assessment methods for carcinogenic or noncarcinogenic chemicals,
quantitative methods for evaluating interindividual variability are not explicitly considered …
quantitative methods for evaluating interindividual variability are not explicitly considered …
[引用][C] Review and evaluation of the potential impact of age-and gender-specific pharmacokinetic differences on tissue dosimetry
HJ CLEWELL, J TEEGUARDEN… - Critical reviews in …, 2002 - pascal-francis.inist.fr
Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic
differences on tissue dosimetry CNRS Inist Pascal-Francis CNRS Pascal and Francis …
differences on tissue dosimetry CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[PDF][PDF] Review and Evaluation of the Potential Impact of Age-and Gender-Specific Pharmacokinetic Differences on Tissue Dosimetry
HJ Clewell, J Teeguarden, T McDonald… - On the incorporation of …, 2002 - academia.edu
In standard risk assessment methods for carcinogenic or noncarcinogenic chemicals,
quantitative methods for evaluating interindividual variability are not explicitly considered …
quantitative methods for evaluating interindividual variability are not explicitly considered …
Review and evaluation of the potential impact of age-and gender-specific pharmacokinetic differences on tissue dosimetry.
HJ Clewell, J Teeguarden, T McDonald… - Critical Reviews in …, 2002 - europepmc.org
In standard risk assessment methods for carcinogenic or noncarcinogenic chemicals,
quantitative methods for evaluating interindividual variability are not explicitly considered …
quantitative methods for evaluating interindividual variability are not explicitly considered …
Review and evaluation of the potential impact of age-and gender-specific pharmacokinetic differences on tissue dosimetry
HJ Clewell, J Teeguarden, T McDonald… - Critical Reviews in …, 2002 - hero.epa.gov
In standard risk assessment methods for carcinogenic or noncarcinogenic chemicals,
quantitative methods for evaluating interindividual variability are not explicitly considered …
quantitative methods for evaluating interindividual variability are not explicitly considered …